236 related articles for article (PubMed ID: 24294364)
21. Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts.
Cao K; Blair CD; Faddah DA; Kieckhaefer JE; Olive M; Erdos MR; Nabel EG; Collins FS
J Clin Invest; 2011 Jul; 121(7):2833-44. PubMed ID: 21670498
[TBL] [Abstract][Full Text] [Related]
22. Mapping of lamin A- and progerin-interacting genome regions.
Kubben N; Adriaens M; Meuleman W; Voncken JW; van Steensel B; Misteli T
Chromosoma; 2012 Oct; 121(5):447-64. PubMed ID: 22610065
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome.
Sánchez-López A; Espinós-Estévez C; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Fanjul V; Riquelme-Borja R; Hamczyk MR; Macías Á; Del Campo L; Camafeita E; Vázquez J; Barkaway A; Rolas L; Nourshargh S; Dorado B; Benedicto I; Andrés V
Circulation; 2021 Nov; 144(22):1777-1794. PubMed ID: 34694158
[TBL] [Abstract][Full Text] [Related]
24. All-trans retinoic acid and rapamycin normalize Hutchinson Gilford progeria fibroblast phenotype.
Pellegrini C; Columbaro M; Capanni C; D'Apice MR; Cavallo C; Murdocca M; Lattanzi G; Squarzoni S
Oncotarget; 2015 Oct; 6(30):29914-28. PubMed ID: 26359359
[TBL] [Abstract][Full Text] [Related]
25. Differential temporal and spatial progerin expression during closure of the ductus arteriosus in neonates.
Bökenkamp R; Raz V; Venema A; DeRuiter MC; van Munsteren C; Olive M; Nabel EG; Gittenberger-de Groot AC
PLoS One; 2011; 6(9):e23975. PubMed ID: 21915271
[TBL] [Abstract][Full Text] [Related]
26. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
[TBL] [Abstract][Full Text] [Related]
27. Coronary artery disease in a Werner syndrome-like form of progeria characterized by low levels of progerin, a splice variant of lamin A.
Hisama FM; Lessel D; Leistritz D; Friedrich K; McBride KL; Pastore MT; Gottesman GS; Saha B; Martin GM; Kubisch C; Oshima J
Am J Med Genet A; 2011 Dec; 155A(12):3002-6. PubMed ID: 22065502
[TBL] [Abstract][Full Text] [Related]
28. New Lmna knock-in mice provide a molecular mechanism for the 'segmental aging' in Hutchinson-Gilford progeria syndrome.
Jung HJ; Tu Y; Yang SH; Tatar A; Nobumori C; Wu D; Young SG; Fong LG
Hum Mol Genet; 2014 Mar; 23(6):1506-15. PubMed ID: 24203701
[TBL] [Abstract][Full Text] [Related]
29. Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin.
Wang Y; Panteleyev AA; Owens DM; Djabali K; Stewart CL; Worman HJ
Hum Mol Genet; 2008 Aug; 17(15):2357-69. PubMed ID: 18442998
[TBL] [Abstract][Full Text] [Related]
30. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin.
McClintock D; Ratner D; Lokuge M; Owens DM; Gordon LB; Collins FS; Djabali K
PLoS One; 2007 Dec; 2(12):e1269. PubMed ID: 18060063
[TBL] [Abstract][Full Text] [Related]
31. Splicing-directed therapy in a new mouse model of human accelerated aging.
Osorio FG; Navarro CL; Cadiñanos J; López-Mejía IC; Quirós PM; Bartoli C; Rivera J; Tazi J; Guzmán G; Varela I; Depetris D; de Carlos F; Cobo J; Andrés V; De Sandre-Giovannoli A; Freije JM; Lévy N; López-Otín C
Sci Transl Med; 2011 Oct; 3(106):106ra107. PubMed ID: 22030750
[TBL] [Abstract][Full Text] [Related]
32. Identification of differential protein interactors of lamin A and progerin.
Kubben N; Voncken JW; Demmers J; Calis C; van Almen G; Pinto Y; Misteli T
Nucleus; 2010; 1(6):513-25. PubMed ID: 21327095
[TBL] [Abstract][Full Text] [Related]
33. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
[TBL] [Abstract][Full Text] [Related]
34. Nuclear localization signal deletion mutants of lamin A and progerin reveal insights into lamin A processing and emerin targeting.
Wu D; Flannery AR; Cai H; Ko E; Cao K
Nucleus; 2014; 5(1):66-74. PubMed ID: 24637396
[TBL] [Abstract][Full Text] [Related]
35. Lamin A, farnesylation and aging.
Reddy S; Comai L
Exp Cell Res; 2012 Jan; 318(1):1-7. PubMed ID: 21871450
[TBL] [Abstract][Full Text] [Related]
36. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells.
Cao K; Graziotto JJ; Blair CD; Mazzulli JR; Erdos MR; Krainc D; Collins FS
Sci Transl Med; 2011 Jun; 3(89):89ra58. PubMed ID: 21715679
[TBL] [Abstract][Full Text] [Related]
37. MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation.
Harhouri K; Navarro C; Depetris D; Mattei MG; Nissan X; Cau P; De Sandre-Giovannoli A; Lévy N
EMBO Mol Med; 2017 Sep; 9(9):1294-1313. PubMed ID: 28674081
[TBL] [Abstract][Full Text] [Related]
38. Modulation of LMNA splicing as a strategy to treat prelamin A diseases.
Lee JM; Nobumori C; Tu Y; Choi C; Yang SH; Jung HJ; Vickers TA; Rigo F; Bennett CF; Young SG; Fong LG
J Clin Invest; 2016 Apr; 126(4):1592-602. PubMed ID: 26999604
[TBL] [Abstract][Full Text] [Related]
39. Progerin in muscle leads to thermogenic and metabolic defects via impaired calcium homeostasis.
Wang WP; Wang JY; Lin WH; Kao CH; Hung MC; Teng YC; Tsai TF; Chi YH
Aging Cell; 2020 Feb; 19(2):e13090. PubMed ID: 31833196
[TBL] [Abstract][Full Text] [Related]
40. Status of treatment strategies for Hutchinson-Gilford progeria syndrome with a focus on prelamin: A posttranslational modification.
Chen X; Yao H; Andrés V; Bergo MO; Kashif M
Basic Clin Pharmacol Toxicol; 2022 Oct; 131(4):217-223. PubMed ID: 35790078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
